Mucosal cytokine profiles in paediatric eosinophilic oesophagitis: a case-control study

Dig Liver Dis. 2014 Jul;46(7):590-5. doi: 10.1016/j.dld.2014.03.003. Epub 2014 Apr 3.

Abstract

Background: Eosinophilic oesophagitis is an inflammatory condition characterized by a dense eosinophilic infiltrate. The migration of eosinophils into the oesophagus is influenced by cytokines such as IL-5, IL-13 and eotaxin-3. The aim of this study was to evaluate changes in the cytokine expression profiles (IL-5, IL-13 and eotaxin-3/CCL26) in children after topical steroid treatment.

Methods: a prospective case-control study was performed in 23 paediatric patients (age 5-16 years) with a histological diagnosis of eosinophilic oesophagitis. Histological evaluation and cytokine levels assay (IL-5, IL-13 and eotaxin-3/CCL26) in the proximal and distal oesophagus were performed before, and after 8 weeks of topical budesonide. Data were compared with a matched healthy control group.

Results: quantitative expression levels of IL-5, IL-13 and eotaxin-3 were significantly higher in the eosinophilic oesophagitis group both compared to healthy subjects (p<0.0001). A significant reduction of the eosinophil infiltrate as well as of IL-5, IL-13 and eotaxin-3 mucosal profiles was observed after steroid treatment both at the proximal and distal oesophagus (p<0.0001).

Conclusions: IL-5, IL-13 and eotaxin-3/CCL26 are significantly over-expressed in the oesophageal epithelium of children with eosinophilic oesophagitis. Topical steroid treatment (inhaled and swallowed budesonide) can induce clinical response with partial mucosal remission.

Keywords: Cytokines; Eosinophilic oesophagitis; Eotaxin-3; IL-13; IL-5; Steroid treatment.

MeSH terms

  • Administration, Topical
  • Adolescent
  • Anti-Inflammatory Agents / administration & dosage
  • Budesonide / administration & dosage
  • Case-Control Studies
  • Chemokine CCL26
  • Chemokines, CC / metabolism
  • Child
  • Cytokines / metabolism*
  • Eosinophilic Esophagitis / drug therapy
  • Eosinophilic Esophagitis / metabolism*
  • Eosinophilic Esophagitis / pathology*
  • Esophagus / metabolism*
  • Female
  • Humans
  • Interleukin-13 / metabolism
  • Interleukin-5 / metabolism
  • Male
  • Mucous Membrane / metabolism
  • Prospective Studies

Substances

  • Anti-Inflammatory Agents
  • CCL26 protein, human
  • Chemokine CCL26
  • Chemokines, CC
  • Cytokines
  • Interleukin-13
  • Interleukin-5
  • Budesonide